Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome
- 1 March 1999
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 55 (3), 1063-1071
- https://doi.org/10.1046/j.1523-1755.1999.0550031063.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In VitroThe Journal of cell biology, 1998
- Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.The Journal of Experimental Medicine, 1994
- Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factorKidney International, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Hypotensive Activity of Fibroblast Growth FactorScience, 1991
- Release of the Vascular Permeability Factor in Minimal Change Nephrotic Syndrome Is Related to CD4+ LymphocytesNephron, 1990
- Loss of Glomerular Polyanion in vitro Induced by Mononuclear Blood Cells from Patients with Minimal-Change Nephrotic SyndromeAmerican Journal of Nephrology, 1986
- Studies of Vascular Permeability Factor derived from T Lymphocytes and Inhibitory Effect of Plasma on Its Production in Minimal Change Nephrotic SyndromeNephron, 1985
- Immunological studies of minimal-change nephropathy.BMJ, 1980